SGS Health Science is a leading CRO providing clinical research and bioanalytical testing with focus on early-stage development and biometrics. SGS offers clinical trial (Phase I to IV) services encompassing full early phase drug development consultancy, clinical project management and monitoring, biometrics, regulatory & medical affairs services. SGS has its own clinical unit in Belgium including a viral challenge testing facility and two phase I patient units based in Belgium and Hungary. SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a high focus in Infectious Diseases, Vaccines, and Respiratory.
